STROMILLO, MARIA LAURA
 Distribuzione geografica
Continente #
NA - Nord America 792
EU - Europa 713
AS - Asia 211
AF - Africa 10
OC - Oceania 10
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.746
Nazione #
US - Stati Uniti d'America 779
IT - Italia 392
CN - Cina 110
IE - Irlanda 71
FR - Francia 58
GB - Regno Unito 34
DE - Germania 33
NL - Olanda 23
VN - Vietnam 21
SE - Svezia 17
TW - Taiwan 16
FI - Finlandia 15
HK - Hong Kong 15
IN - India 13
UA - Ucraina 13
RU - Federazione Russa 12
CA - Canada 11
JP - Giappone 11
AU - Australia 10
KR - Corea 6
ZA - Sudafrica 6
ES - Italia 5
PT - Portogallo 5
SG - Singapore 5
CL - Cile 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BE - Belgio 3
CH - Svizzera 3
GR - Grecia 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DZ - Algeria 2
HU - Ungheria 2
IL - Israele 2
MT - Malta 2
MX - Messico 2
PK - Pakistan 2
RO - Romania 2
TH - Thailandia 2
A1 - Anonimo 1
AL - Albania 1
AR - Argentina 1
BR - Brasile 1
EE - Estonia 1
ET - Etiopia 1
IR - Iran 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 1.746
Città #
Siena 107
Fairfield 83
Dublin 65
Houston 61
Woodbridge 55
Santa Cruz 52
Ashburn 47
Seattle 42
Buffalo 41
Milan 35
Wilmington 31
Beijing 30
Columbus 22
Cambridge 21
Dong Ket 21
Ann Arbor 20
Rome 19
Southend 18
Stockholm 16
Taipei 15
Amsterdam 13
San Diego 12
Wuhan 11
Boardman 9
Helsinki 9
Bengaluru 8
Florence 8
Shanghai 8
Sydney 8
Turin 8
Changchun 7
Chicago 7
Chengdu 6
Dearborn 6
Hangzhou 6
Los Angeles 6
Muizenberg 6
Nanjing 6
Orbassano 6
Phoenix 6
Naples 5
Pisa 5
Singapore 5
Baltimore 4
Carnaxide 4
Crugers 4
Duncan 4
Forlì 4
Guangzhou 4
Hefei 4
Las Vegas 4
Madison 4
Padova 4
Palermo 4
Paris 4
Toronto 4
Arzano 3
Ascoli Piceno 3
Bari 3
Cascina 3
Chiyoda-ku 3
Council Bluffs 3
Fairborn 3
Frankfurt am Main 3
Gainesville 3
Lake Forest 3
Mérignac 3
New York 3
Pontedera 3
Saint Petersburg 3
Turku 3
Udine 3
Yellow Springs 3
Aarhus 2
Albano Sant'Alessandro 2
Ancona 2
Beringen 2
Bitetto 2
Bologna 2
Boulder 2
Brescia 2
Cardiff 2
Castrolibero 2
Catania 2
Central 2
Changsha 2
Dallas 2
Darmstadt 2
Geneva 2
Genoa 2
Granby 2
Gurgaon 2
Imsida 2
Kirkland 2
Lahore 2
Lappeenranta 2
Marana 2
Miami 2
Monza 2
Moschiano 2
Totale 1.129
Nome #
null, file e0feeaa5-e161-44d2-e053-6605fe0a8db0 336
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context, file e0feeaaa-85b5-44d2-e053-6605fe0a8db0 196
Long-term assessment of no evidence of disease activity in relapsing-remitting MS, file e0feeaa5-dc74-44d2-e053-6605fe0a8db0 189
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis, file e0feeaa9-d8da-44d2-e053-6605fe0a8db0 149
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis, file e0feeaa5-e36f-44d2-e053-6605fe0a8db0 140
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability, file e0feeaa7-1f4c-44d2-e053-6605fe0a8db0 135
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies, file 68a5d1ae-ffc0-4a42-a405-da8111468fa9 128
Deep gray matter volume loss drives disability worsening in multiple sclerosis, file e0feeaa7-1df9-44d2-e053-6605fe0a8db0 85
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study, file e0feeaa8-2078-44d2-e053-6605fe0a8db0 74
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures, file e0feeaa5-e034-44d2-e053-6605fe0a8db0 69
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies, file e0feeaaa-c1e8-44d2-e053-6605fe0a8db0 62
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France, file e0feeaaa-cf7d-44d2-e053-6605fe0a8db0 52
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?, file 4095b478-155c-4c0c-8436-72c335c2d124 31
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative, file fb48f674-3121-4be7-8523-d6705c3ccefa 30
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization, file e0feeaa9-492f-44d2-e053-6605fe0a8db0 15
The Use of Social Media and Digital Devices Among Italian Neurologists, file 74b80aab-8112-4c94-9b48-a43765c3f600 14
Signs and symptoms of Covid‐19 in patients with multiple sclerosis, file 44300896-a0e4-4dad-921a-e1e8b51c1a49 9
Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28, file e0feeaa5-afb9-44d2-e053-6605fe0a8db0 7
Cladribine vs other drugs in MS: Merging randomized trial with real-life data, file e0feeaa9-4e34-44d2-e053-6605fe0a8db0 7
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study, file e0feeaaa-c399-44d2-e053-6605fe0a8db0 6
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies, file 4e0400f8-4d53-42bd-9331-a7e115189b59 5
Signs and symptoms of Covid‐19 in patients with multiple sclerosis, file 6fefdc00-d693-4c9e-b254-b05e1bf29f12 4
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study, file c0c4464a-566c-42ab-b470-4d76016f4a81 4
Structural and Metabolic Brain Abnormalities in Preclinical Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy, file e0feeaa4-d973-44d2-e053-6605fe0a8db0 4
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy, file 0c8eb4ee-fde1-42b9-bbcf-a4e5849a7088 3
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies, file 44a803c6-6b51-43bc-8311-84d89e25f8e0 3
Scoring treatment response in patients with relapsing multiple sclerosis, file e0feeaa4-f718-44d2-e053-6605fe0a8db0 3
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy, file 6b19b561-9805-42a5-93ee-5b7504a6edfb 2
Impaired vasoreactivity in mildly disabled CADASIL patients, file e0feeaa4-ca92-44d2-e053-6605fe0a8db0 2
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)., file e0feeaa4-e8b1-44d2-e053-6605fe0a8db0 2
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder., file e0feeaa5-03ec-44d2-e053-6605fe0a8db0 2
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study, file e0feeaa5-dde3-44d2-e053-6605fe0a8db0 2
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS, file e0feeaa7-1aa5-44d2-e053-6605fe0a8db0 2
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome, file e0feeaa7-a364-44d2-e053-6605fe0a8db0 2
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome, file e0feeaa7-ab98-44d2-e053-6605fe0a8db0 2
The dilemma of benign multiple sclerosis: Can we predict the risk of losing the “benign status”? A 12-year follow-up study, file e0feeaa7-fb78-44d2-e053-6605fe0a8db0 2
Assessing response to interferon-β in a multicenter dataset of patients with MS, file e0feeaa9-bc53-44d2-e053-6605fe0a8db0 2
Hippocampal atrophy in vascular MCI as biomarker of subclinical memory impairment, file 2d5bede8-2bf8-4d4d-9963-0f2da16ccf73 1
Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients, file 37085fa1-e59c-4dd8-a90b-9a5cb4bccdfd 1
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis, file e0feeaa4-da64-44d2-e053-6605fe0a8db0 1
Short-Term Combination of Glatiramer Acetate with IV Steroid Treatment Preceding Treatment with GA Alone Is Associated with early Suppression of MRI-disease activity in Patients with Relapsing Remitting Multiple Sclerosis, file e0feeaa4-da67-44d2-e053-6605fe0a8db0 1
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery., file e0feeaa4-ddf6-44d2-e053-6605fe0a8db0 1
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL, exon 2 mutation., file e0feeaa4-e2ac-44d2-e053-6605fe0a8db0 1
Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy., file e0feeaa4-e431-44d2-e053-6605fe0a8db0 1
Refining response to treatment as defined by the Modified Rio Score, file e0feeaa4-ffce-44d2-e053-6605fe0a8db0 1
null, file e0feeaa5-0605-44d2-e053-6605fe0a8db0 1
Efficacy and safety of intravenous immunoglobulin treatment in refractory Behcet's Disease with different organ involvement: a case series, file e0feeaa5-ce48-44d2-e053-6605fe0a8db0 1
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients, file e0feeaa6-0650-44d2-e053-6605fe0a8db0 1
Post-stroke depression: Research methodology of a large multicentre observational study (DESTRO), file e0feeaa7-2647-44d2-e053-6605fe0a8db0 1
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study, file e0feeaa7-5b53-44d2-e053-6605fe0a8db0 1
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery., file e0feeaa7-9733-44d2-e053-6605fe0a8db0 1
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis, file e0feeaa7-ee62-44d2-e053-6605fe0a8db0 1
Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis, file e0feeaa9-94dc-44d2-e053-6605fe0a8db0 1
Totale 1.796
Categoria #
all - tutte 8.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201923 0 0 0 0 0 0 0 0 0 0 0 23
2019/2020188 22 13 18 20 18 21 15 17 20 7 8 9
2020/2021261 5 12 10 29 8 23 18 23 25 41 36 31
2021/2022391 22 41 16 42 70 18 26 25 12 14 81 24
2022/2023449 8 16 84 71 43 56 37 38 40 22 19 15
2023/2024353 11 32 20 37 32 42 55 16 5 14 41 48
Totale 1.796